Company Description
Zhongchao Inc. provides healthcare information, education, and training services in the People’s Republic of China.
The company offers patient management services in the tumor and rare diseases field; internet healthcare services, and pharmaceutical services, as well as operates an online information platform.
It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content, as well as sells patent drugs.
The company offers its services through its MDMOOC online platform, including MDMOOC mobile App, MOOC Medical WeChat subscription account, and MDMOOC website; and patient management services through IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program.
It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers.
The company was founded in 2012 and is headquartered in Shanghai, China.
| Country | China |
| Founded | 2012 |
| IPO Date | Feb 24, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 142 |
| CEO | Weiguang Yang |
Contact Details
Address: 841 Yan An Middle Road, Jing An District, Nanxi Creative Center, Suite 218 Shanghai, F4 200040 China | |
| Phone | 021-32205987 |
| Website | izcmd.com |
Stock Details
| Ticker Symbol | ZCMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001785566 |
| CUSIP Number | G9897X107 |
| ISIN Number | KYG9897X1079 |
| SIC Code | 8200 |
Key Executives
| Name | Position |
|---|---|
| Weiguang Yang | Founder, Chairman, President and Chief Executive Officer |
| Pei Xu | Chief Financial Officer, Secretary and Director |
| Shuang Wu | Chief Operating Officer |
| Baoqian Tian | Chief Sales Officer |
| Xuejun Chen | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 23, 2024 | F-3 | Filing |
| Apr 30, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Mar 18, 2024 | 6-K | Report of foreign issuer |
| Feb 29, 2024 | 6-K | Report of foreign issuer |
| Feb 27, 2024 | 6-K | Report of foreign issuer |
| Feb 20, 2024 | 6-K | Report of foreign issuer |
| Jan 12, 2024 | 6-K | Report of foreign issuer |
| Jan 3, 2024 | 6-K | Report of foreign issuer |
| Dec 22, 2023 | 6-K | Report of foreign issuer |
| Jul 7, 2023 | 6-K | Report of foreign issuer |